ELISA kits enable precise measurement of mental health biomarkers, accelerating discoveries that improve treatments for millions worldwide.
Tag:
biomarkers
Semaglutide, a drug widely used for diabetes and weight management, is now being tested in major trials for its potential to slow early-stage Alzheimer’s disease.
- Clinical Psychology & Psychotherapy
Inflammatory Biomarkers Identified as Key Indicators in Depression
A recent review of studies has highlighted the growing significance of inflammatory biomarkers in understanding the complexities of major depressive disorder (MDD).
- Health & Fitness
Study Finds Mood Interventions Can Improve Inflammatory Biomarkers in Inflammatory Bowel Disease
A new meta-analysis has revealed that interventions targeting mood disorders can lead to significant reductions in inflammatory biomarkers in individuals with inflammatory bowel disease.
Stroke is the leading cause of disability worldwide and the second leading cause of death, but the right early intervention can prevent severe consequences.
Many neurodegenerative diseases, including Alzheimer’s and Parkinson’s, are difficult to diagnose before symptoms begin to appear.
Measuring markers of cellular metabolism has become an important approach to studying mental illnesses and developing new ways to diagnose, treat, and prevent them.
Extreme stressors like psychiatric disorders or childhood neglect and abuse can lead to a range of health problems later in life, including depression, anxiety, and cardiovascular disease.
- Health & Fitness
Protein Implicated in Tumour Growth Found to Be Heavily Associated with Pancreatic Cancer
When Nancy Klauber-DeMore, MD, began studying secreted frizzled-related protein 2, or SFRP2, it was as a breast cancer researcher and surgeon.
A new study uses brain imaging and machine learning to identify altered functional brain connectivity (FC) in people with autism.
- Health & Fitness
This Wireless, Handheld, Non-Invasive Device Detects Alzheimer’s and Parkinson’s Biomarkers
An international team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer’s and Parkinson’s diseases.
In a new study, researchers use a very large dataset to identify predictive brain imaging-based biomarkers of mental illness in adolescents.
Until recently, our understanding of Parkinson’s disease has been quite limited, which has been apparent in the limited treatment options and management of this debilitating condition.
Sophisticated systems for the detection of biomarkers are crucial for real-time diagnostic and disease-monitoring devices.
The human body is made up of millions of different cells that work together to perform a variety of functions.
